Turning employee sentiment into hard operational data

Tern plc

Standard wellbeing programmes rarely solve the problems that matter. They tend to be broad, reactive, and detached from how a business actually runs. Managers see participation figures or survey responses and assume all is well.

That gap is now being addressed by tools built leadership decision-making. Instead of asking employees to rate how they feel, these tools extract meaning from how people actually speak, in comments, conversations and open-ended feedback.

Talking Medicines is one of the companies leading this shift. Its PeopleVoice platform translates employee language into operational insight. If a team is struggling with direction or motivation, it shows up early, before it hits output. It’s quantifiable risk data, broken down by cohort, trend and theme. And that data can be used to act precisely, not generally.

The strongest use cases are emerging in teams with high turnover or shifting targets. Instead of issuing another pulse survey or resilience webinar, leaders can see which roles are losing clarity, where communication is falling apart, or which functions are beginning to disengage.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Fundamental XR expands access to immersive training with web-enabled platform

Its new Immersive Web platform brings immersive training into the browser, lowering adoption barriers and broadening enterprise reach.

GLP-1 receptor agonists: Strategic market shift

Rapid uptake, evolving regulation and digital integration are reshaping the investment case for metabolic health therapies.

The Cyber Resilience Act forces a security reset for connected device makers

Device Authority helps manufacturers operationalise Cyber Resilience Act compliance through automated device identity and secure update management.

Pharmaceutical groups move closer to the consumer in strategic marketing reset

Pharmaceutical marketing is shifting towards direct consumer engagement, reshaping how companies compete and manage risk in a digital environment.

Changing clinician behaviour reshapes commercial strategy for 2026

As clinician engagement becomes more digital and measurable, companies that act on behavioural data can improve targeting, reduce risk and strengthen competitive positioning in 2026.

Tern Plc launches £384,408 Open Offer at 0.40p per share

Tern Plc has announced an Open Offer to raise up to £384,408 through the issue of up to 96,101,957 shares at 0.40p each, a 20% discount to the 12 February 2026 closing price.

Search

Search